Allergic reactions to carboplatinHENDRICK, A. M; SIMMONS, D; CANTWELL, B. M. J et al.Annals of oncology. 1992, Vol 3, Num 3, pp 239-240, issn 0923-7534Article

Factors for Hematopoietic Toxicity of Carboplatin: Refining the Targeting of Carboplatin Systemic ExposureSCHMITT, Antonin; GLADIEFF, Laurence; PINGUET, Frédéric et al.Journal of clinical oncology. 2010, Vol 28, Num 30, pp 4568-4574, issn 0732-183X, 7 p.Article

Oxaliplatin-induced immune pancytopeniaTALEGHANI, Behrouz Mansouri; FONTANA, Stefano; MEYER, Oliver et al.Transfusion (Philadelphia, PA). 2005, Vol 45, Num 5, pp 704-708, issn 0041-1132, 5 p.Article

CisplatinMEENAKSHI DABHOLKAR; CHRISTIAN, M; REED, E et al.Cancer chemotherapy and biological response modifiers annual. 1994, Vol 15, pp 87-98, issn 0921-4410Article

General pharmacology of cis-malonato [(4R,5R)-4,5-bis-(aminomethyl)-2-isopropyl-1,3-dioxalone]platinum(II)KIM, D.-K; AHN, J. S; RUY, G et al.Arzneimittel-Forschung. 1994, Vol 44, Num 9, pp 1080-1088, issn 0004-4172Article

Cisplatin-Induced Downregulation of OCTN2 Affects Carnitine WastingLANCASTER, Cynthia S; CHAOXIN HU; FRANKE, Ryan M et al.Clinical cancer research (Print). 2010, Vol 16, Num 19, pp 4789-4799, issn 1078-0432, 11 p.Article

Positive direct and indirect antiglobulin tests associated with oxaliplatin can be due to drug antibody and/or drug-induced nonimmunologic protein adsorptionARNDT, Patricia; GARRATTY, George; ISAAK, Edahn et al.Transfusion (Philadelphia, PA). 2009, Vol 49, Num 4, pp 711-718, issn 0041-1132, 8 p.Article

Modulation of cis-diamminedichloroplatinum(II) resistance : a reviewTIMMER-BOSSCHA, H; MULDER, N. H; DE VRIES, E. G. E et al.British journal of cancer. 1992, Vol 66, Num 2, pp 227-238, issn 0007-0920Article

CisplatinREED, E.Cancer chemotherapy and biological response modifiers annual. 1992, Vol 13, pp 83-90, issn 0921-4410Article

The interaction of platinum complexes with DNA studied by differential scanning calorimetryNUNOMURA, K; MAEDA, Y; OHTSUBO, E et al.Journal of General and Applied Microbiology. 1991, Vol 37, Num 2, pp 207-214, issn 0022-1260Article

A note on the solution chemistry of carboplatin in aqueous solutionsLEDERER, M; LEIPZIG-PAGANI, E.International journal of pharmaceutics. 1998, Vol 167, Num 1-2, pp 223-228, issn 0378-5173Article

RAB8 Enhances TMEM205-Mediated Cisplatin ResistanceSHEN, Ding-Wu; GOTTESMAN, Michael M.Pharmaceutical research. 2012, Vol 29, Num 3, pp 643-650, issn 0724-8741, 8 p.Article

Cisplatin-conjugated degradable gelatin microspheres: fundamental study in vitroOHTA, S; NITTA, N; SONODA, A et al.British journal of radiology. 2009, Vol 82, Num 977, pp 380-385, issn 0007-1285, 6 p.Article

Utilization of a Right-handed Coiled-coil Protein from Archaebacterium Staphylothermus marinus as a Carrier for CisplatinERIKSSON, Mathilda; HASSAN, Saadia; DALIANIS, Tina et al.Anticancer research. 2009, Vol 29, Num 1, pp 11-18, issn 0250-7005, 8 p.Article

Ghrelin Prevents Cisplatin-Induced Mechanical Hyperalgesia and CachexiaGARCIA, José M; CATA, Juan P; DOUGHERTY, Patrick M et al.Endocrinology (Philadelphia). 2008, Vol 149, Num 2, pp 455-460, issn 0013-7227, 6 p.Article

Sodium Thiosulfate Administered Six Hours after Cisplatin Does Not Compromise Antineuroblastoma ActivityHARNED, Theresa M; KALOUS, Ondrej; NEUWELT, Alexander et al.Clinical cancer research. 2008, Vol 14, Num 2, pp 533-540, issn 1078-0432, 8 p.Article

Reversible Posterior Leukoencephalopathy Syndrome Associated With OxaliplatinPINEDO, Daryl M; SHAH-KHAN, Farheen; SHAH, Prabodh C et al.Journal of clinical oncology. 2007, Vol 25, Num 33, pp 5320-5321, issn 0732-183X, 2 p.Article

Evaluation of an alternate dosing strategy for cisplatin in patients with extreme body surface area valuesLOOS, Walter J; DE JONGH, Felix E; SPARREBOOM, Alex et al.Journal of clinical oncology. 2006, Vol 24, Num 10, pp 1499-1506, issn 0732-183X, 8 p.Article

Flat dosing of carboplatin is justified in adult patients with normal renal functionEKHART, Corine; DE JONGE, Milly E; HUITEMA, Alwin D. R et al.Clinical cancer research. 2006, Vol 12, Num 21, pp 6502-6508, issn 1078-0432, 7 p.Article

Dix ans de carboplatinePUJADE-LAURAINE, Eric; ARMAND, Jean-Pierre.Bulletin du cancer. 2000, Vol 87, Num AOU, issn 0007-4551, 53 p., NSSerial Issue

An analysis of potential factors allowing an individual prediction of cisplatin-induced anaemiaPIVOT, X; GUARDIOLA, E; MILANO, G et al.European journal of cancer (1990). 2000, Vol 36, Num 7, pp 852-857, issn 0959-8049Article

Individualisation de dose du carboplatine en chimiothérapie = Dose individualisation for carboplatin in cancer chemotherapyOUDARD, S; PUJADE LAURAINE, E.Bulletin du cancer. 1997, Vol 84, Num 6, pp 675-677, issn 0007-4551Article

Pharmacokinetics, tissue distribution, and excretion of cis-malonato[(4R,5R)-4,5-bis(aminomethyl)-2-isopropyl-1,3-dioxolane]platinum(II) in dogsYONG-BAIK CHO; KIM, K. H; DAE-KEE KIM et al.Drug metabolism and disposition. 1995, Vol 23, Num 11, pp 1280-1285, issn 0090-9556Article

A water-soluble 1,2-diaminocyclohexaneplatinum(II) complex containing procaine hydrochloride : synthesis and antiproliferative activity in vitroCAFAGGI, S; ESPOSITO, M; PARODI, B et al.Pharmazie. 1994, Vol 49, Num 8, pp 617-618, issn 0031-7144Article

Mécanismes moléculaires de résistance au cisplatine = Molecular mecanism of cisplatin resistanceRIXE, O; VALVEZ, V; DELALOGE, S et al.Cahiers d'oncologie. 1994, Vol 3, Num 2, pp 55-62, issn 0941-3804Article